Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study

Title
Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study
Authors
Keywords
-
Journal
mAbs
Volume 3, Issue 3, Pages 289-298
Publisher
Informa UK Limited
Online
2011-07-07
DOI
10.4161/mabs.3.3.15532

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now